News | December 20, 2023
Vijaya Diagnostic to acquire P H Diagnostic for Rs. 134.65 Cr
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
Additionally, Rs. 12.85 crores shall be infused into the P H Diagnostic by way of either Equity or Loan to pay the existing debt
10+ emerging markets, Japan & ANZ transition in final phase
Fischer Chemic will make an entry into the growing market of diagnostic imaging industry with innovative and disruptive technologies
Expands patient reach to remotest towns by furthering investment in GoApptiv
Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Laurus Labs concluded the acquisition by securing the remaining 8,333 equity shares from the promoter group shareholders
Lack of technology transfer stands out as a formidable barrier
Subscribe To Our Newsletter & Stay Updated
